epidemiological investigation of iranian patients with pulmonary embolism based on medication

Background: the primary cause of mortality in pulmonary embolism (pe) is believed to be the lack of emergency treatment.objectives: this study aimed to assess the outcomes of primary treatment and evaluate complications based on the type of medication used in iranian pe patients after hospital discharge. methods: this retrospective study was conducted on 108 pe patients admitted to shohada tajrish hospital, tehran, iran, during 2018 - 2019. clinical manifestations, treatment methods, drug-related complications, and prognosis were analyzed within six months post-discharge. results: a significant association was observed between underlying diseases and the mortality rate (p < 0.05). the frequency of prescribed medications in pe patients was as follows: 60% for rivaroxaban, 9% for apixaban, 14% for warfarin, and 17.5% for enoxaparin. no significant correlation was found between death, bleeding, and the type of drug used. conclusions: the increased mortality rate in pe patients is strongly associated with underlying conditions, such as cancer. the use of anticoagulants significantly reduces mortality rates in pe patients.